- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02803814
Pancreatoduodenectomy in Pancreatic and Periampullary Tumors (DUOPAN-EPAM)
Pancreatoduodenectomy in Pancreatic and Periampullary Tumors: Initial Approach of the Superior Mesenteric Artery Versus Classical Approach: A Prospective, Randomized, Multicenter Study
Background: Recently it has been observed in pancreatic cancer that after apparently complete surgical resection, histological examination of the surgical specimen according to a standard protocol reveals tumor infiltration of the surgical margin in more than 50% of patients. To increase the resection margin and reduce such high infiltration rate, a new surgical approach based on the initial dissection of the superior mesenteric artery has been advocated.
Aims: To compare the rate of free resection margin (R0) and oncological results of two possible approaches to perform a pancreaticoduodenectomy in tumors of the head of the pancreas and peripancreatic area: the classic approach versus the initial approach of the superior mesenteric artery.
Methodology: Prospective, randomized, multicenter study in which patients with pancreatic and periampullary tumors undergo a pancreaticoduodenectomy. In a group the classical approach from the superior mesenteric vein will be performed and in the other group an initially dissecting the superior mesenteric artery approach will be carried out. 116 patients are required and the main variables considered are: free margin rates (R0) or infiltrated by tumor (R1), postoperative morbidity, mortality, local and systemic recurrence, disease-free interval and survival at 1, 3 and 5 years.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Valencia, Spanien, 46010
- Hospital Clínico Universitario de Valencia
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patients with pancreatic and periampullary tumors undergo a pancreaticoduodenectomy
Exclusion Criteria:
- Patients with hepatic or peritoneal metastasis
- Patients with irresectable tumor
- Patients with R2 resection
- Patients Grade IV of the American Society of Anesthesiology Score
- Patients with neoadjuvant treatment
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Superior mesenteric artery approach
Initial approach of the superior mesenteric artery to perform a pancreaticoduodenectomy in tumors of the head of the pancreas and peripancreatic area
|
Pancreaticoduodenectomy in tumors of the head of the pancreas and peripancreatic area using the superior mesenteric artery approach
|
|
Aktiv komparator: Classic approach
Classic approach to perform a pancreaticoduodenectomy in tumors of the head of the pancreas and peripancreatic area
|
Pancreaticoduodenectomy in tumors of the head of the pancreas and peripancreatic area using the classical approach
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Rate of free resection margin (R0)
Tidsramme: 1 month
|
Histological examination of the surgical specimen
|
1 month
|
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- DUOPAN-EPAM
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Pancreatic and Periampullary Tumors
-
Andrei IagaruIkke længere tilgængeligCarcinoide tumorer | Islet Cell (Pancreatic NET) | Andre neuroendokrine tumorerForenede Stater
-
I-Mab Biopharma US LimitedBristol-Myers SquibbRekrutteringMavekræft | Solid tumor | Metastatisk kræft | Avanceret kræft | Esophageal Adenocarcinom | PDAC - Pancreatic Ductal Adenocarcinoma | Galdevejskræft (BTC) | Gastroøsofageal Junction CarcinomForenede Stater, Kina
-
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)RekrutteringIkke-småcellet lungekræft | NSCLC | Avanceret lungekarcinom | Solid tumor, voksen | Metastatisk pancreas ductal adenokarcinom | PDAC - Pancreatic Ductal Adenocarcinoma | KRAS G12D | Metastatisk ikke-små lungekræft | KRAS G12V | KRAS G12C | Metastatisk kolorektal cancer (CRC) | KRAS G12A | KRAS G12S | CRC (kolorektal cancer)Forenede Stater, Australien
Kliniske forsøg med Superior mesenteric artery approach for pancreatoduodenectomy
-
Asan Medical CenterRekrutteringGentagende tumor | Kræft i bugspytkirtlen, voksen | Operation Site Fistel | Margin, TumorfriKorea, Republikken
-
Fundación Pública Andaluza para la gestión de la...AfsluttetMetastase | Bugspytkirteltumor | Cirkulerende tumorceller | Periampullært karcinom ResektabeltSpanien
-
Tianjin Medical University Cancer Institute and...The First Affiliated Hospital with Nanjing Medical University; Shanxi Province... og andre samarbejdspartnereUkendt
-
Universitair Ziekenhuis BrusselRekruttering